|
Dr. Stewart trained in Medical Oncology at Stanford University, then served as a member of the faculty of the School of Medicine at Vanderbilt University for more than twelve years. He has more than eight years of experience in the biotechnology industry, joining Matrix Pharmaceutical, Inc. in 1997 as Associate Medical Director. From 1998 until 2001, he was Clinical Scientist on the Herceptin project at Genentech where he guided post-marketing clinical development including the adjuvant breast cancer program. He moved to ALZA Corporation as Senior Medical Director. From 2001 to 2005, he was employed at Corixa Corporation where he rose from Senior Medical Director to Vice President, Clinical Research. Dr. Stewart holds a B.A. degree from Rice University, and an M.D. from Baylor College of Medicine. In addition to training in Medical Oncology, he did postdoctoral medical training in Internal Medicine at Case Western Reserve University and postdoctoral scientific training in the laboratory of Dr. Ronald Levy at Stanford University. | 